|
Gene: C17orf89 |
Gene summary for C17ORF89 |
Gene summary. |
Gene information | Species | Human | Gene symbol | C17orf89 | Gene ID | 284184 |
Gene name | NADH:ubiquinone oxidoreductase complex assembly factor 8 | |
Gene Alias | C17orf89 | |
Cytomap | 17q25.3 | |
Gene Type | protein-coding | GO ID | GO:0006996 | UniProtAcc | A1L188 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
284184 | C17orf89 | P65T-E | Human | Esophagus | ESCC | 2.12e-37 | 7.68e-01 | 0.0978 |
284184 | C17orf89 | P74T-E | Human | Esophagus | ESCC | 2.68e-59 | 1.87e+00 | 0.1479 |
284184 | C17orf89 | P75T-E | Human | Esophagus | ESCC | 5.21e-44 | 1.03e+00 | 0.1125 |
284184 | C17orf89 | P76T-E | Human | Esophagus | ESCC | 2.90e-59 | 1.35e+00 | 0.1207 |
284184 | C17orf89 | P79T-E | Human | Esophagus | ESCC | 4.74e-43 | 1.01e+00 | 0.1154 |
284184 | C17orf89 | P80T-E | Human | Esophagus | ESCC | 1.58e-63 | 2.12e+00 | 0.155 |
284184 | C17orf89 | P82T-E | Human | Esophagus | ESCC | 3.36e-17 | 1.09e+00 | 0.1072 |
284184 | C17orf89 | P83T-E | Human | Esophagus | ESCC | 1.44e-72 | 2.69e+00 | 0.1738 |
284184 | C17orf89 | P84T-E | Human | Esophagus | ESCC | 1.84e-06 | 5.53e-01 | 0.0933 |
284184 | C17orf89 | P89T-E | Human | Esophagus | ESCC | 2.66e-29 | 2.18e+00 | 0.1752 |
284184 | C17orf89 | P91T-E | Human | Esophagus | ESCC | 8.66e-22 | 2.76e+00 | 0.1828 |
284184 | C17orf89 | P94T-E | Human | Esophagus | ESCC | 1.43e-02 | 8.33e-01 | 0.0879 |
284184 | C17orf89 | P104T-E | Human | Esophagus | ESCC | 2.25e-03 | 8.10e-01 | 0.0931 |
284184 | C17orf89 | P107T-E | Human | Esophagus | ESCC | 3.40e-91 | 2.48e+00 | 0.171 |
284184 | C17orf89 | P126T-E | Human | Esophagus | ESCC | 8.31e-08 | 1.12e+00 | 0.1125 |
284184 | C17orf89 | P127T-E | Human | Esophagus | ESCC | 3.64e-20 | 2.68e-01 | 0.0826 |
284184 | C17orf89 | P128T-E | Human | Esophagus | ESCC | 5.30e-73 | 2.56e+00 | 0.1241 |
284184 | C17orf89 | P130T-E | Human | Esophagus | ESCC | 1.20e-96 | 2.04e+00 | 0.1676 |
284184 | C17orf89 | S43 | Human | Liver | Cirrhotic | 2.32e-08 | -2.82e-01 | -0.0187 |
284184 | C17orf89 | HCC1_Meng | Human | Liver | HCC | 5.29e-79 | 4.79e-01 | 0.0246 |
Page: 1 2 3 4 5 6 7 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0471418 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0471419 | Breast | Precancer | Thermogenesis | 68/684 | 232/8465 | 4.40e-22 | 1.26e-20 | 9.69e-21 | 68 |
hsa0471424 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0471434 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0471443 | Breast | DCIS | Thermogenesis | 74/846 | 232/8465 | 8.72e-21 | 3.13e-19 | 2.30e-19 | 74 |
hsa0471453 | Breast | DCIS | Thermogenesis | 74/846 | 232/8465 | 8.72e-21 | 3.13e-19 | 2.30e-19 | 74 |
hsa0471439 | Esophagus | HGIN | Thermogenesis | 91/1383 | 232/8465 | 1.97e-17 | 5.36e-16 | 4.25e-16 | 91 |
hsa04714114 | Esophagus | HGIN | Thermogenesis | 91/1383 | 232/8465 | 1.97e-17 | 5.36e-16 | 4.25e-16 | 91 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0471422 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa0471432 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa0471412 | Stomach | GC | Thermogenesis | 56/708 | 232/8465 | 1.35e-13 | 4.32e-12 | 3.04e-12 | 56 |
hsa0471413 | Stomach | GC | Thermogenesis | 56/708 | 232/8465 | 1.35e-13 | 4.32e-12 | 3.04e-12 | 56 |
hsa0471421 | Stomach | CAG with IM | Thermogenesis | 55/640 | 232/8465 | 7.01e-15 | 2.23e-13 | 1.56e-13 | 55 |
hsa0471431 | Stomach | CAG with IM | Thermogenesis | 55/640 | 232/8465 | 7.01e-15 | 2.23e-13 | 1.56e-13 | 55 |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |